Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

Donald Trump went after Tylenol again in a Truth Social post Friday, urging pregnant women to avoid the drug, causing parent ...

Tylenol, Kenvue’s biggest product, has been sold over-the-counter in the United States since the 1960s and makes up about 10% of group sales. Rothschild estimated that sales to expectant mothers ...

Kenvue Inc. (NYSE:KVUE) has been in the news lately after President Trump asserted that taking Tylenol can increase autism in ...

Fintel reports that on September 26, 2025, Rothschild & Co upgraded their outlook for Kenvue (NYSE:KVUE) from Neutral to Buy. Analyst Price Forecast Suggests 41.75% Upside As of September 13, 2025, ...

President’s claim linking active ingredient to developmental disorders came amid pending arguments to overturn dismissal ...

Moderately bullish activity in Kenvue Inc (KVUE), with shares up 6c, or 0.4%, near $16.23. Options volume roughly in line with average with 55k ...

In a statement, a Kenvue spokesperson said the company believes it will continue to be successful in the litigation as the ...

Former US President Donald Trump reiterated controversial health warnings, advising pregnant women against Tylenol and urging ...

The company’s guidance "has not changed: Acetaminophen is the safest pain reliever option for pregnant women as needed ...

Eczema affects many infants, causing dry, itchy skin. The Indian Academy of Pediatrics recommends gentle bathing, mild ...

The pharmaceutical company behind Tylenol privately acknowledged the likelihood of an association between its drug in pregnancy and neurodegenerative disorders like autism in children seven years ago, ...